$AGIO Recent Headlines 15 small-cap stocks Gol

$AGIO Recent Headlines

15 small-cap stocks Goldman Sachs says are worth a look 11:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 7:28 a.m. April 7, 2014 - Sara Sjolin

Jim Cramer's Top Stock Picks: AGIO AAPL LUV 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14) 5:29 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Let's Hear It for the Bull 8:20 p.m. Sept. 16, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO): Today's Weak On High Volume Stock 10:08 a.m. Sept. 12, 2014 - TheStreet.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Aug. 27, 2014 - InvestorPlace.com
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q2 2014 Results - Earnings Call Transcript 4:10 p.m. Aug. 9, 2014 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 5:18 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
8 Biotechnology Stocks to Buy Now 5:00 a.m. Aug. 6, 2014 - InvestorPlace.com
Goldman's picks in small caps 12:45 p.m. Aug. 5, 2014 - Seeking Alpha
25 Small-Cap Stocks to Buy 8:18 a.m. July 23, 2014 - InvestorPlace.com
Agios Presents Data on AG-221 - Analyst Blog 5:21 p.m. June 16, 2014 - Zacks.com
Agios drug designated an orphan drug for AML 8:58 a.m. June 16, 2014 - Seeking Alpha
Biotech Stocks Get Turbo Boost From Idenix Deal 6:45 p.m. June 11, 2014 - Seeking Alpha
Agios Initiates Trial on AG-348 - Analyst Blog 4:35 p.m. June 10, 2014 - Zacks.com
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates 8:03 a.m. June 6, 2014 - TheStreet.com
SA PRO: Top Long And Short Ideas, Friday May 16 5:00 a.m. May 17, 2014 - Seeking Alpha
J.P.Morgan's Geoff Meacham Plucks Biotechs With Upside From A Down Market 9:17 a.m. May 16, 2014 - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:34 a.m. May 16, 2014 - Seeking Alpha
10-Q: AGIOS PHARMACEUTICALS INC 4:07 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q1 2014 Results - Earnings Call Transcript 1:43 p.m. May 8, 2014 - Seeking Alpha


Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 8:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 7:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 11:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 9:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 1:30 p.m. July 15, 2014 - PR Newswire - PRF
Flagship Ventures Adds Pharma Industry Veteran Roger J. Pomerantz, M.D., F.A.C.P. as Senior Partner 9:00 a.m. July 14, 2014 - PR Newswire - PRF
Orphan Drug Designations, Financial Results, Board Elections, and Raised Financial Guidance - Analyst Notes on Agios, Alder, Healthways, NeoGenomics and Sequenom 6:10 a.m. July 2, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia 8:02 a.m. June 16, 2014 - BusinessWire - BZX
New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies 7:31 a.m. June 14, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration 8:03 a.m. June 13, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK Deficiency, a Rare, Hemolytic Anemia 8:02 a.m. June 9, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Flagship Ventures Commences Its Sixth VentureLabs™ Fellowship Program Focused On Entrepreneurial Innovation 9:00 a.m. June 5, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present at the Goldman Sachs 35th Annual Global Healthcare Conference 9:03 a.m. June 4, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present New Clinical Data from AG-221 Ongoing Phase 1 Study at the 19th Congress of the European Hematology Association 4:44 a.m. May 22, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 7:00 a.m. May 19, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Appoints Chris Bowden, M.D., as Chief Medical Officer 8:32 a.m. May 14, 2014 - BusinessWire - BZX